Rationale: Blood-brain-barrier (BBB) breakdown and cerebral edema result from postischemic inflammation and contribute to mortality and morbidity after ischemic stroke. A functional role for the carcinoembryonic antigenrelated cell adhesion molecule 1 (CEACAM1) in the regulation of reperfusion injury has not yet been demonstrated.
E very year, ischemic stroke accounts for ≈10% of global deaths, leaving 5 million patients permanently disabled, not only in high-income, but also in less-developed countries. 1 Besides the primary hypoxic damage and secondary processes, such as excitotoxicity, recruitment of inflammatory cells following restoration of cerebral perfusion contributes to ischemic brain injury. 2, 3 Especially, inflammatory events occurring at the blood-brain barrier (BBB) during cerebral ischemia are critical for the pathogenesis of tissue damage in ischemic stroke. Cell adhesion molecules (eg, intercellular adhesion molecule 1 4 and the selectins) 5 are involved in the development of postischemic brain inflammation by promoting cell adhesion, migration, and activation of leukocytes. Although genetic deficiency or antibody blocking of cellular adhesion molecules, such as intercellular adhesion molecule 1 and platelet selectin, demonstrated attenuated cerebral damage in mice, [5] [6] [7] links between early BBB breakdown and the innate immune response are still not fully understood. Neutrophils are an essential component of the innate immune system and among the first cells to adhere to the cerebral endothelium and infiltrate the ischemic brain. 8 This postischemic inflammation leads to impairment of BBB function and neuronal damage by release of matrix metalloproteinases (MMPs), for example MMP-9 and proinflammatory cytokines, including interleukin (IL)-1β, as well as reactive oxygen species. 9 September 27, 2013
Thus, understanding the regulation of neutrophils at the ischemic BBB will provide novel insights into secondary vascular and parenchymal injury after ischemic stroke. In this context, carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1), a member of the immunoglobulin superfamily, which is highly expressed on neutrophils and endothelia, is an interesting candidate regulator of BBB function and maintenance. In contrast to classical proinflammatory cell adhesion molecules, such as intercellular adhesion molecule 1, CEACAM1 is a known inhibitory immune coreceptor that suppresses signal transduction via 2 immunoreceptor tyrosine-based inhibition motifs in its long cytoplasmic domain. 10, 11 Neisseria spp. and other pathogens bind to CEACAM1 to dampen the host inflammatory response. 11, 12 Congruently, lack of CEACAM1 expression results in hyperactivation of neutrophils and increased mortality in a model of Listeria monocytogenes infection as a result of increased neutrophil liver infiltration and elevation of inflammatory cytokine levels. 13 Although the role of CEACAM1 in controlling neutrophilic granulocyte function has been studied extensively in bacterial infections, 13, 14 it remains unclear whether CEACAM1 also exhibits a negative regulatory role in sterile inflammation. To address this question, we use the transient occlusion of the middle cerebral artery to induce ischemic stroke in CEACAM1-competent and CEACAM1 null mouse lines to investigate the role of CEACAM1 in postischemic reperfusion injury. Our data demonstrate that CEACAM1-expressing neutrophils are important regulators of reperfusion injury that dampen exacerbation of inflammation and breakdown of the BBB after ischemic stroke.
Methods

Animals
All animal experiments were approved by the local animal care committee (Behörde für Soziales, Familie, Gesundheit und Verbraucherschutz, Hamburg) and conducted after the recommendations for research in basic stroke studies. 15 Cerebral ischemia was induced in 10-to 12-week-old male, C57BL/6 wild-type (WT), and CEACAM1-deficient mice (Ceacam1 −/− -mice), described previously. 16 Ceacam1 −/− mice were backcrossed for least 10 generations.
Induction of Cerebral Ischemia and Neurological Scoring
Mice were randomized and experiments were performed in a blinded fashion. Focal cerebral ischemia was induced in 10-to 12-weekold male mice by temporary occlusion of the middle cerebral artery (tMCAO) with a silicone-coated microfilament for 60 minutes as described. 8, 17 Bederson's test 18 was used to determine global neurological function according to the following scoring system: 0, no deficit; 1, preferential turning; 2, circling; 3, longitudinal spinning; 4, no movement; and 5, death. The detailed experimental description can be found in Online Data Supplement methods section.
Stroke Assessment by MRI
MRI was performed 24 h and 14 days after stroke on a dedicated 7T MR small animal imaging system (ClinScan, Bruker, Ettlingen, Germany). The image protocol comprised T2-weighted imaging, diffusion-weighted imaging, and 3D time-of-flight angiography and steady-state susceptibility contrast−enhanced MRI. Calculations of edema, corrected stroke volumes, and noninvasive quantification of brain edema were performed as described by Gerriets et al. 19 Detailed MRI sequence parameters can be found in the Online Data Supplement methods section.
Assessment of BBB Breakdown
BBB breakdown was assessed as described. 20 For quantification of extravasated Evans blue into the stroke tissue, mice were injected IV with 2% solution of Evans blue in normal saline (4 mL/kg of body weight) 4 h postsurgery. Evans blue was allowed to circulate for 4 h. Mice were euthanized and perfused with 50 mL of ice-cold phosphate-buffered saline. Brains were removed, cut into 1-mm slices, and stroke sizes were documented by 2,3,5-triphenyltetrazolium chloride staining. Evans blue was extracted in 50% trichloroacetic acid (Sigma-Aldrich, St Louis, MO), and dye concentrations were quantified photometrically at 540 nm/600 nm.
Flow Cytometric Analyses
Flow cytometry was performed as described. 8 Animals were euthanized and perfused with phosphate-buffered saline. After removal of the meninges and dissection into ipsilateral and contralateral hemispheres, brains were enzymatically digested followed by a Percoll gradient centrifugation step to remove myelin. The resulting single cell suspensions were incubated with the appropriate antibody cocktails followed by analyses with a LSR Fortessa flow cytometer (BD Pharmingen, Franklin Lakes, NJ) and FACS Diva software (version 6.1.3, BD Pharmingen, Franklin Lakes, NJ). The antibodies used in this study are listed in the Antibody reference list in the Online Data Supplement methods section.
Histological Analyses
Histological analyses were performed as described. 17 Briefly, mice were deeply anesthetized with isoflurane inhalant and perfused through the left ventricle using 10-mL phosphate-buffered saline followed by 50 mL of cold 4% paraformaldehyde. Brains were then stained according to standard immunohistochemistry procedures with antibodies listed in the Antibody reference list in the Online Data Supplement methods section. For analysis of autoptic human brain, tissue sections were selected from the files of the Institute of Neuropathology at the University Medical Center Hamburg-Eppendorf. Brains had been fixed in 4% paraformaldehyde for at least 3 weeks before paraffin-embedding. Brain sections (3 μm) were stained according to standard immunohistochemistry procedures.
Zymography
Zymography was performed according to the manufacturer's instructions (Life Technologies Ltd, Darmstadt, Germany). Briefly, 30 µg of each brain lysate were loaded on a 10% gelatin gel; zymograms were renaturated and developed with zinc-containing buffers. Gels were stained with Coomassie Brilliant Blue and areas of protease activity seemed as clear bands.
Neutrophil Isolation and Stimulation With N-Formylmethionyl-Leucyl-Phenylalanine
Neutrophils were isolated as described. 21 Briefly, neutrophils were enriched from bone marrow following negative selection with an antibody cocktail-depleting lymphocytes and natural killer cells (see Antibody reference list in the Online Data Supplement methods section). Purity of isolated neutrophils was by light microscopy and by flow cytometry (data not shown, purity>90%). After isolation, 1×10 6 neutrophils were stimulated with 1 µmol/L N-formylmethionyl-leucyl-phenylalanine (Sigma-Aldrich, 
Nonstandard Abbreviations and Acronyms
Inhibition of MMP-9 With SB-3CT
MMP-9 inhibition was performed as previously described. 22 Briefly, 2-[[(4-phenoxyphenyl)sulfonyl]methyl]-thiirane (SB-3CT; 25 mg/kg body weight, Enzo Life Sciences GmbH, Lörrach, Germany) was injected IP as a suspension in a vehicle solution (10% dimethyl sulfoxide in normal saline). SB-3CT was administered 2 h and 5 h after stroke induction. Control groups received vehicle solution instead.
Statistical Analyses
For statistical analysis, Prism Graph version 4.0 software (GraphPad Software, La Jolla, CA) was used. 
Results
CEACAM1 + Cells Infiltrate the Ischemic Brain Lesion During Postischemic Inflammation
Ischemia and reperfusion alter the expression of adhesion molecules on microvessels and leukocytes. 4 To document whether the cellular adhesion molecule, CEACAM1, displays changes in its expression pattern after ischemic stroke, we analyzed basic vascular anatomy and CEACAM1 expression in Ceacam1 −/− and WT mice before and after ischemic brain injury. In vascular corrosion casts and laser Doppler flowmetry, we confirmed that no anatomic deviations in the cerebral vascular trees were produced by deletion of the Ceacam1 gene in unchallenged Ceacam1 −/− and WT mice (Online Figure I ). In the uninjured brain, CEACAM1 was only expressed on endothelial cells (EC; Online Figure II ). This expression pattern changed during the first 24 h of postischemic inflammation. In whole brain lysates, we found increased CEACAM1 expression in the ipsilateral compared with the contralateral hemisphere after induction of the ischemic stroke, whereas CEACAM1 was only expressed on basal levels in sham-operated mice ( Figure 1A ). After stroke, CEACAM1 was predominantly expressed on CD11b + cells, but not microglia ( Figure 1B ; inlay; asterisk symbol), as demonstrated by histological analysis of ischemic brain sections ( Figure 1B ). Further differentiation of these cells by flow cytometry revealed that only neutrophils, macrophages, and dendritic cells expressed high levels of CEACAM1 ( Figure 1C ), whereas microglia ( Figure 1C ) and lymphocytes (data not shown) expressed CEACAM1 on very low levels. Additionally, immunohistochemical staining of postmortem adult human brain sections confirmed these findings. We found no CEACAM1 expression in the uninjured brain but prominent influx of CEACAM1 + cells 24 h after stroke, which were also identified as neutrophils ( Figure 1D ). These data show that CEACAM1 + neutrophils are among the earliest inflammatory leukocyte population to infiltrate the ischemic brain.
CEACAM1 Improves Outcome After Ischemic Stroke
Accumulation of neutrophils in infarcted cerebral tissue correlates with severity of secondary tissue damage and poor neurological outcome. 23, 24 We, therefore, hypothesized that absence of the inhibitory function of CEACAM1 could negatively influence BBB function and stroke outcome. , and in human brain tissue (D). Increased levels of CEACAM1 were detected in ipsilateral brain lysates (A). In histological sections, an influx of CD11b + CEACAM1 + cells was detected (B). CD11b-labeling is shown in green, CEACAM1 expression is shown in red, nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI), blue; scale bar=50 µm (B). Flow cytometry analyses identified granulocytes, macrophages, and dendritic cells (DCs) as CEACAM1-expressing cells (C). In human brain sections, an influx of CEACAM1-expressing cells was also observed (D; shown after peroxidase-assisted detection of CEACAM1). The infiltrating CEACAM1-positive cells (red) showed positive staining for myeloperoxidase (MPO, green) but not CD68 (green), indicating that in human stroke, only neutrophils express CEACAM1 but not macrophages (D, lower row); scale bar=50 µm. H&E indicates hematoxylin and eosin; and WT, wild type. September 27, 2013
Following this idea, CEACAM1-competent and Ceacam1 −/− mice were subjected to tMCAO to analyze infarct volumes (Figures 2 and 3 ). Twenty-four hours after stroke, we found that Ceacam1 −/− mice had ≈30% larger infarcts compared with WT mice (Figure 2A ; 34.79±4.06 mm 3 versus 43.72±4.44 mm 3 ; P<0.001). Observing increased midline shift in Ceacam1 −/− , edema was measured with a noninvasive method, which highly correlates with absolute brain water content. 19 This analysis revealed that Ceacam1 −/− mice developed more pronounced cerebral edema ( Figure 2B ; 9.53±3.36% versus 14.17±3.88% increase of the ipsilateral hemisphere volume; P=0.0018), resulting in lower cortical and striatal perfusion rates compared with the contralateral hemispheres ( Figure 2C : striatal: 0.87±1.03% versus −2.40±3.59%; P=0.0083; cortical: 6.42±2.62% versus 2.41±7.35%; P=0.0051). We investigated whether this larger tissue damage in Ceacam1 −/− mice was also functionally relevant by scoring the mice according to Bederson test, which rates poststroke neuronal function and morbidity. 18 In these scores, Ceacam1 −/− mice performed significantly worse compared with WT mice, which became evident by significant higher frequencies in circling (Bederson score 2), longitudinal spinning (Bederson score 3), and poststroke mortality (Bederson score 5) in the Ceacam1-negative genotype ( Figure 3A ; P=0.0364 on d1; P=0.031 on d2; P<0.0001). The increased poststroke morbidity in Ceacam1 −/− mice was also associated with a remarkably delay in body weight gain as a consequence of reduced motility and neurological performance ( Figure 3B ; at d14, 99.47±5.26% versus 90.76±4.44% of the initial weight; P=0.0005). The overall poststroke survival of mice was significantly lower compared with WT animals ( Figure 3C ; 57% versus 100% in WT mice). After 2 , survival (C), and brain atrophy (D) were recorded for 14 days. On day 1 and 2, significant differences in the neurological scores between the 2 genotypes were observed (A). Body weight gain (B), survival rate (C), and brain atrophy (D) were aggravated in Ceacam1 −/− mice. Data are presented as mean with 95% confidence intervals; Bederson scores are shown without line or error bar; *P<0.05, **P<0.001, ***P<0.0001; weight development and brain atrophy were evaluated with the Mann-Whitney U test; Bederson scores were compared with the Wilcoxon signed-rank test; survival was analyzed by the χ 2 test (survival rate); each white and black symbol represents data from 1 wild-type (WT) or Ceacam1 −/− animal.
weeks, we found that Ceacam1 −/− mice displayed significantly larger brain atrophy compared with CEACAM1-competent mice ( Figure 3D ; 2.35±3.91 mm 3 versus 10.38±9.95 mm 3 ; P=0.0189), whereas the degree of vascular remodeling and angiogenesis did not differ significantly between the mouse lines (Online Figure III) .
Taken together, we found increased stroke volumes and cerebral edema, associated with decreased cerebral perfusion, and overall worse outcome in the absence of CEACAM1 suggesting that CEACAM1 is involved in early pathophysiological cascades after ischemic stroke.
Increased BBB Breakdown in Ceacam1 −/− Mice
Increase in BBB permeability during ischemic stroke lead to influx of plasma proteins and subsequently to formation of the cerebral edema. 25 Because we observed increased cerebral edema in Ceacam1 −/− mice, we suspected that impaired BBB function was related to the worse outcome in Ceacam1 −/− mice after stroke. Therefore, we investigated stability of the BBB during reperfusion after intravenous injection of Evans blue ( Figure 4 ) and with MRI (Online Figure IV) . We observed increased perivascular staining with Evans blue, indicative of a more severe BBB breakdown in the CEACAM1-negative genotype ( Figure 4A ; 1.9±0.7 versus 3.1±0.8-fold increase of Evans blue intensity; P<0.0001). In both cortical and striatal strokes, enhanced Evans blue extravasation was observed in Ceacam1 −/− mice. Normalization of extravasated Evans blue to the stroke volume demonstrated that BBB breakdown was independent of the stroke size in Ceacam1 −/− mice ( Figure 4B ; 5.24±1.20 ng/mm 3 in WT versus 12.41±1.54 ng/ mm 3 in Ceacam1 −/− mice), whereas sham mice showed similar basal Evans blue leakage in both genotypes ( Figure 4C ; 6.377±1.839 µg/g in WT versus 5.086±0.8558 µg/g in Ceacam1 −/− mice). No differences were observed in serum levels of Evans blue that served as an internal standard to document comparable abundance of intravascular dye ( Figure 4D ; 0.0985±0.0155 ng/µL in WT versus 0.1070±0.0105 ng/µL in Ceacam1 −/− mice).
Increased Levels of MMP-9 Exacerbate BBB Breakdown and Tissue Damage in Ceacam1 −/− Mice
Based on these findings, we went on to further define the underlying cause for more severe BBB breakdown in Ceacam1 −/− mice. Irreversible cerebrovascular permeability after stroke is caused by MMP-9, which is produced by different cell types, such as myeloid cells, glial cells, and EC. [26] [27] [28] We analyzed the infiltrating inflammatory cells to identify the cell population that expresses MMP-9 and is causally involved in BBB breakdown in our model. Because we showed that CEACAM1 is prominently expressed in CD11b + cells, namely neutrophils, and neutrophils were identified as the principal cell population present in the infarcted areas ( Figure 1B and 1C) , we characterized their spatial distribution and secretion products in our model after 8 h (Online Figure V ) and 24 h ( Figure 5 ). We observed increased accumulation of CD11b + MMP-9 + cells in Ceacam1 −/− ischemic hemispheres compared with WT mice ( Figure 5A ; Online Figure VB and VC). Furthermore, only neutrophils expressed MMP-9 in significant amounts among myeloid cells during the first phase of the postischemic inflammation ( Figure 5B ). To date, a link between CEACAM1 expression on neutrophils and the regulation of MMP-9 production has not been reported. Consistent with our histological observations, flow cytometry analyses of the ischemic brains also revealed significantly higher absolute numbers of neutrophils in the ischemic hemispheres of Ceacam1 −/− mice ( Figure 5C Semiquantitative immunohistochemical analysis demonstrated higher BBB breakdown (A). This effect was independent of stroke size as shown in B. No differences of Evans blue leakiness was observed in sham-operated mice. Serum levels of Evans blue were measured as an internal control (D). A, Representative microscopic images of brain sections after injection of Evans blue (red), scale bar: 2 mm. The stroke area was identified with anti-microtubule-associated protein 2 (MAP-2) antibodies (white; the stroke area did not stain positive for MAP-2, black areas, marked with white dots). B, Representative macroscopic images of Evans blue leakage (blue) combined with 2,3,5-tetrazolium chloride-life/dead staining (the infarcted area is shown in white) of cortical (B, upper row) and striatal strokes (B, lower row). Data are presented as mean with 95% confidence intervals; data were evaluated with the Mann-Whitney U test; each white and black symbol represent data from 1 wild-type (WT) or Ceacam1 −/− animal, in A, each white and black symbol represents data from 1 WT or Ceacam1 −/− brain section. tMCAO indicates temporary occlusion of the middle cerebral artery. September 27, 2013 group). Normalization of the infiltrating cell numbers relative to resident microglia proved a solely higher influx of neutrophils into the ischemic hemispheres of Ceacam1 −/− mice ( Figure 5D and 5E). Macrophage numbers were comparable 24 h postinfarction between the different genotypes (numbers of infiltrating neutrophils were normalized to microglia: 0.0784±0.0471 in WT versus 0.2914±0.0996 in Ceacam1 −/− mice; and neutrophil numbers were correlated to macrophages: 0.1789±0.1187 in WT versus 0.2876±0.1560 in Ceacam1 −/− mice [ Figure 5D and 5E]). In addition, we evaluated total MMP-9 activity in brain homogenisates from sham controls and mice 8 h and 24 h after tMCAO. High MMP-9 levels and activity were confirmed in ispilateral hemispheres from Ceacam1 −/− mice ( Figure 6A and 6B; (Online Figure VE and VF) . Expectedly, MMP-9 levels and activity in the contralateral hemispheres were comparable between both genotypes (Online Figure VI) , indicating that higher MMP-9 levels in ischemic hemispheres of Ceacam1 −/− mice resulted from postischemic inflammation. Moreover, we identified 200-kDa MMP-9 dimers in zymography that identify neutrophils as a major source of MMP-9 in our model, because these dimers are specifically secreted by neutrophils. 29 Flow cytometric analyses of MMP-9 expression in neutrophils also revealed elevation of MMP-9 levels in CEACAM1-negative neutrophils ( Figure 6C ; MMP-9 levels are expressed as differences Figure 6 . Matrix metalloproteinase-9 (MMP-9) expression is increased in brain lysates and neutrophils of Ceacam1 −/− mice compared with wild-type (WT) mice. MMP-9 levels were measured in whole brain lysates by Zymography (A, upper row) and Western blotting (A, lower row). Intracellular MMP-9 levels in neutrophils were analyzed by flow cytometry (B and C) and secretion of MMP-9 by neutrophils was measured after in vitro stimulation with 1 µmol/L N-formylmethionyl-leucyl-phenylalanine (D). Analysis of MMP-9 mean fluorescence intensity (MFI) in neutrophils showed higher amounts of MMP-9 in carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1)-deficient neutrophils in vivo (B and C). In vitro stimulation of neutrophils confirmed these results with higher MMP-9 secretion by CEACAM1-deficient neutrophils after 120 min (D). Data are shown as mean with 95% confidence intervals. *P<0.05, **P<0.001, ***P<0.0001; relative infiltration and relative MFI were analyzed with the nonparametric Mann-Whitney U test. Data from WT mice are represented by white squares and from Ceacam1 −/− mice in black squares. One symbol represents data from 1 animal.
in mean fluorescence intensity after normalization to a MMP-9-negative cell population (microglia); 29.32±8.99 in WT versus 42.07±11.48 in Ceacam1 −/− cells; P=0.0281). To prove that CEACAM1 participates in the regulation of MMP-9 levels in neutrophils, we performed in vitro stimulation of untouched neutrophils from CEACAM1-compentent and Ceacam1 −/− mice with N-formylmethionyl-leucyl-phenylalanine. We demonstrate that exposure of primary neutrophils to N-formylmethionylleucyl-phenylalanine induces secretion of significantly higher levels of MMP-9 over time in Ceacam1 −/− mice compared with WT, indicating a CEACAM1-dependent regulation of MMP-9 production ( Figure 6D ).
Inhibition of MMP-9 With SB-3CT Produces a Phenocopy of WT Infarction Sizes in Ceacam1 −/− Mice
Because we show a causative role for CEACAM1 in controlling neutrophilic MMP-9 secretion, we hypothesized whether inhibition of MMP-9 activity was sufficient to reduce postischemic inflammation in the CEACAM1 null mice after tMCAO and to improve their poststroke outcome. Hence, we repeated our experiments in the presence of an MMP-9 inhibitor, SB-3CT in vivo. 24 h after tMCAO, we observed that SB-3CT application ameliorated the exacerbation of ischemic brain damage in Ceacam1 −/− mice ( Figure 7A : stroke volumes: 28.25±4.46 mm 3 , WT with SB-3CT, n=8, versus 32.15±3.12, Ceacam1 −/− mice with SB-3CT, n=8, versus 38.26±1.51 mm 3 , WT animals with vehicle control, n=4, versus 45.84±3.98 mm 3 , Ceacam1 −/− animals with vehicle control, n=5; Figure 7B : edema: 8.57±2.38%, WT with SB-3CT, versus 8.69±1.93%, Ceacam1 −/− mice with SB-3CT, versus 12.38±1.25% WT animals with vehicle control, versus 17.56±2.36%, Ceacam1 −/− animals with vehicle control; Figure 7C : perfusion: striatal: 4.51±2.69%, cortical: 16.56±6.57%, WT with SB-3CT; striatal: 4.32±2.34%, cortical: 15.10±7.79% Ceacam1 −/− mice with SB-3CT; striatal: −0.03±1.68%, cortical: 12.93±6.94%, WT animals with vehicle control; striatal: −5.15±2.31%, cortical: −2.37±4.78%, Ceacam1 −/− animals with vehicle control).
Importantly, the cerebral influx of neutrophils into the ischemic hemispheres of Ceacam1 −/− mice was diminished to that WT levels after treatment with SB-3CT and led to improved survival of the Ceacam1 −/− mice ( Figure 7D and 7E; cerebral influx of neutrophils: 20.33±5.171%, WT treated with SB-3CT, n=4, versus 13.28±6.72, Ceacam1 −/− mice treated with SB-3CT, n=5; survival rates: 83.3% Ceacam1 −/− mice/+SB-3CT versus 60% Ceacam1 −/− mice without SB-3CT). Figure 7 . Inhibition of matrix metalloproteinase-9 (MMP-9) in Ceacam1 −/− mice decreases stroke size to wild-type (WT) levels. After inhibition of MMP-9, stroke sizes (A, representative T2 images), cerebral edema (B), arterial spin-labeled perfusion (C, representative ASL perfusion maps) were measured with MRI 24 h after temporary occlusion of the middle cerebral artery. Infiltrating neutrophils were examined by flow cytometry (D), and survival was recorded over a time course of 3 days (E). Neutralization of MMP-9 improved outcome of Ceacam1 −/− mice to WT levels. Histological analysis showed that MMP-9 is not only coexpressed by murine carcinoembryonic antigen-related cell adhesion molecule 1 positive (CEACAM1 + ) cells (F, left), but also by human cells (F, right) in the ischemic hemispheres (CEACAM1 expression is shown in red, MMP-9 in green, 4',6-diamidino-2-phenylindole [DAPI] in blue, scale bar=50 µm). Data are presented as mean with 95% confidence intervals; *P<0.05, **P<0.001, ***P<0.0001; data from stroke volume, edema, perfusion measurements, and quantification of infiltrating cells were analyzed with a Bonferroni-corrected ANOVA; each white and black square represents data from 1 WT or Ceacam1 −/− animal; each white and black symbol represents data from 1 WT or Ceacam1 −/− animal. September 27, 2013
These data demonstrate that CEACAM1 + neutrophils are a critical determinant in the regulation of BBB breakdown; because CEACAM1 is a functionally and structurally conserved molecule, we were prompted to analyze whether human CEACAM1 + neutrophils could also potentially attribute to MMP-9-mediated BBB breakdown during cerebral ischemic insult. As shown in Figure 7F , MMP-9 + CEACAM1 + neutrophils are present both in murine and human ispsilateral hemispheres. Hence, it is tempting to assume that CEACAM1 may also contribute to reperfusion injury after ischemic stroke in humans.
Discussion
In this study, we report on the function of CEACAM1 in inflammation after ischemic stroke. We demonstrate that lack of CEACAM1 expression on neutrophils leads to exacerbation of BBB breakdown and increased neutrophil infiltration into the ischemic hemispheres. As a consequence, extensive cerebral edema, reduced cerebral perfusion, and worse overall outcome were observed in Ceacam1 −/− mice. Cerebral edema after BBB breakdown contributes to severe morbidity and mortality after ischemic stroke and is a major therapeutical challenge. Although decompressive hemicraniectomy after malignant MCA territory infarction has reduced stroke-associated mortality rates from 71% to 22%, still 31% of these patients are left severely disabled (modified Rankin scale score 4). 30 Therefore, early therapeutic intervention and reestablishment of perfusion are the immediate goals of poststroke treatment, albeit that restoration of cerebral blood flow causes reperfusion injury with exacerbated inflammation-induced tissue damage. 31 In inflammation after cerebral ischemia, proinflammatory cytokines, IL-1β, IL-6, tumor necrosis factor-α, monocyte chemotactic protein-1, and reactive oxygen species are released by necrotic and injured tissue. Consequently, astrocytes, microglia, and EC are activated, which initiates the postischemic inflammatory response. 2, 3, 9 During this phase, induction of leukocyte adhesion molecules on cerebral microvessels and circulating leukocytes triggers leukocyte adhesion and extravasation and cytokine-induced remodeling of EC-EC tight junctions. In parallel, disruption of EC-EC junctions and enzymatic degradation of the perivascular extracellular matrix (mainly by MMP-9) destabilize the vasculature and facilitate plasma protein and leukocyte extravasation leading to formation of the vasogenic edema. 28, 32 The vasogenic edema is a result of biphasic BBB breakdown caused by activated MMP-2 and the cytokine-inducible MMPs stromelysin (MMP-3) and MMP-9. The breakdown of the BBB is initially reversible. It is largely catalyzed by MMP-2, but subsequent release of IL-1β, tumor necrosis factor-α, and the influx of neutrophils induce MMP-3 and MMP-9 activity producing irreversible breakdown of the BBB. 25, 33, 34 Therefore, it is important to identify novel proteins or specific cell types involved in regulation of MMP-9 production in ischemic stroke. Recent reports highlighted the immunomodulatory role of CEACAM1 on myeloid and ECs at the inflammatory endothelial interface. 13, 14, 16, 35, 36 We and others described CEACAM1 as a regulator of vascular homeostasis and integrity decreasing basal and acute vascular permeability. [36] [37] [38] Under hypoxic conditions, CEACAM1 is up-regulated after hypoxic preconditioning in myocardial ischemia on myocardiocytes and endothelia and was suspected to elicit cardioprotective effects. 39 Furthermore, CEACAM1expressing myeloid cells catalyze collateral formation and improve tissue perfusion after permanent femoral artery occlusion in mouse model for hindlimb ischemia. 16 We demonstrate up-regulation of CEACAM1 in the ischemic hemisphere after stroke due to an influx of CEACAM1 + neutrophils. CEACAM1 is an immunoreceptor tyrosine-based inhibition motif-containing pathogen receptor inhibits the inflammatory response elicited by toll-like receptor 4-CEACAM1 complex formation on neutrophils in response to pathogen challenge, leading to reduction of proinflammatory cytokine production. 11, 13, 14 Ischemia and reperfusion injury share many phenotypic parallels with bacterial infections, such as signaling through pattern-recognition molecules (toll-like receptors), leukocyte adhesion molecule-dependent recruitment and activation of immune cells of the innate and adaptive immune system and endothelial activation. 40 Interestingly, reperfusion injury is reduced in mouse lines with systemic deletion of leukocyte or endothelial adhesion molecules, eg, intercellular adhesion molecule 1, platelet selectin, or toll-like receptor 4. 6, 41, 42 To date, it has not been investigated whether CEACAM1 had any inhibitory effects on sterile inflammation in cerebral reperfusion injury. Hence, one could argue that CEACAM1 exerts neuroprotective effects by enhancing EC-cell contacts, and thus, limiting vascular permeability. As presented here, systemic deletion of the Ceacam1 gene did not increase basal cerebral endothelial permeability. Contradicting these results, vascular hyperpermeability in Ceacam1 −/− mice has been reported in endothelium of the lung, in tumors, and after topical application of mustard oil or injection of vascular endothelial growth factor. 36, 38 However, we reported earlier that endothelial CEACAM1 is of a lesser vasoprotective relevance during vascular remodeling, because transfer of CEACAM1 + myeloid cells into CEACAM1-deficient hosts could remedy defects in collateral formation and wound healing. On the contrary, depletion of CEACAM1 + CD11b + granulocyte antigen 1 + cells compromised this beneficial effect. 16 This suggests that BBB breakdown and cerebral endothelial permeability are not solely influenced by endothelial CEACAM1 expression, but rather involve CEACAM1-expressing inflammatory cells. In addition, the cerebral vasculature consists of a specialized endothelium that is devoid of fenestrations and is highly impermeable. 43 Therefore, absence of vascular endothelial CEACAM1 may be of minor impact on cerebral vessel stability.
Because we observed an apparent increase of neutrophil influx into the ischemic hemispheres of Ceacam1 −/− mice, we focused on these inflammatory cells to identify a novel CEACAM1-dependent mechanism attributing to the integrity of the BBB. Excessive neutrophil infiltration into tissues correlates with increase in MMP-9 production. Furthermore, the induction of irreversible cerebrovascular permeability after stroke is substantially caused by MMP-9. 33, 44 Therefore, we analyzed presence and distribution of MMP-9 in our model. Both in vivo and in vitro analyses showed increased MMP-9 induction in CEACAM1-deficient neutrophils, suggestive of a disturbed regulation of MMP-9 synthesis and activation. The significant accumulation of neutrophils in ipsilateral hemispheres of Ceacam1 −/− mice may be both, cause or consequence of elevated MMP-9 activity, because MMP-9 degrades the basal lamina and impairs vessel stabilization, but simultaneously also stimulates neutrophil migration. 45 Various cytokines, including IL-1β, can induce MMP-9. 46 Recently, Lu et al 14 identified CEACAM1 as a down-regulator of inflammasome activation and IL-1β production in neutrophils. Hence, we also assumed that exaggerated inflammatory cytokine release contributed to enhanced MMP-9 induction in CEACAM1-negative backgrounds. The source of MMP-9 after ischemic stroke, however, is still discussed controversially: although endothelial-adherent and infiltrating neutrophils were identified as the main source of MMP-9 that is responsible for the early loss of BBB integrity in the first 24 h, 27, 47 it was also suggested that neutrophils do not contribute to MMP-9 activity in insulted tissue. 48 Still, our analysis of the composition and activities of gelatinase-type MMPs revealed high levels of neutrophil-specific dimeric MMP-9 isoforms in brain lysates from Ceacam1 −/− mice. 29 In flow cytometric and histological analyses, our data add further proof that MMP-9 was indeed secreted by neutrophils. Moreover, it is of note that high MMP-9 levels correlate with infarction growth, poor neurological outcome, increased risk of hemorrhagic transformation, and intracranial hemorrhage. 34 In inhibition experiments, we demonstrate that reduction of MMP-9 activity alone can compensate for loss of CEACAM1 expression, in that stroke sizes, neutrophil influx, and survival in Ceacam1 −/− mice were alleviated to WT levels. Therefore, MMP-9 inhibition is sufficient to produce a phenocopy of CEACAM1-competent animals in Ceacam1 −/− mice, corroborating the causal role for CEACAM1-mediated regulation of MMP-9 production by neutrophils. This assumption is profoundly supported by the herein presented immunohistological labelings of human poststroke autoptic brains, where we identified cerebral influx of human neutrophilic granulocytes as the principal source of MMP-9.
In summary, we described the contribution of CEACAM1 to the pathophysiology of reperfusion injury, BBB breakdown, and cerebral edema in a mouse model for ischemic stroke. We demonstrated for the first time that CEACAM1 dampened inflammation in reperfusion injury by controlling MMP-9 levels in neutrophils. As a consequence, lower MMP-9 levels decreased BBB breakdown, diminished secondary tissue damage, and improved neurological outcome and survival after ischemic stroke. Moreover, our analysis of human autoptic brain tissue showed that the CEACAM1 + neutrophils might be involved in the pathophysiology of ischemic stroke in humans. Future studies will need to be conducted to address a putative analogous function of human and murine CEACAM1 in ischemic stroke and reperfusion injury.
What Is Known?
• Blood-brain-barrier (BBB) breakdown, reperfusion injury, and poststroke inflammation determine stroke-associated morbidity and mortality. • Levels of BBB-disrupting matrix metalloproteinase-9 (MMP-9) in the infarcted areas are elevated by leukocyte influx and activation of endothelial and brain-resident leukocyte populations. • The carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is an essential regulator of vascular integrity (vascular remodeling) and leukocyte activity in infections and in the resolution of inflammation.
What New Information Does The Article Contribute?
• Loss of CEACAM1 enhances BBB breakdown, subsequent increase of stroke sizes, and exacerbates poststroke inflammation. • Neutrophilic MMP-9 levels are regulated by CEACAM1 at the ischemic BBB.
• CEACAM1 deficiency can be functionally compensated by MMP-9 inhibition. Thus, stroke outcome is determined by the CEACAM1dependent regulation of neutrophilic MMP-9 production.
The mechanisms underlying edema formation after stroke are poorly defined. In this study, we demonstrate a link between the cellular adhesion molecule, CEACAM1, and the extent of BBB breakdown. We found that CEACAM1 is a negative regulator of MMP-9 production by neutrophils, and therefore, protects from metalloproteinase-induced BBB damage. The loss of CEACAM1 results in an increase in cerebral vascular permeability producing larger infarction sizes, increased tissue damage, poor neurological outcome, and higher mortalities. These changes can be reversed by MMP-9 inhibition. Altogether, these findings reveal for the first time a negative regulator for cerebral edema formation after stroke. Hence, the modulation of CEACAM1-mediated effects might offer a new venue for understanding and future interventions in cerebral edema formation after stroke.
Novelty and Significance
